Itron Q2 Adj $1.21 Beats $0.96 Estimate, Sales $609.07M Beat $599.10M Estimate
Portfolio Pulse from Benzinga Newsdesk
Itron (NASDAQ:ITRI) reported strong Q2 earnings, with adjusted EPS of $1.21 beating the $0.96 estimate and sales of $609.07M surpassing the $599.10M estimate. This represents significant year-over-year growth in both earnings and sales.
August 01, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Itron reported strong Q2 earnings, with adjusted EPS of $1.21 beating the $0.96 estimate and sales of $609.07M surpassing the $599.10M estimate. This represents significant year-over-year growth in both earnings and sales.
Itron's Q2 earnings and sales both exceeded analyst expectations, showing strong year-over-year growth. This positive financial performance is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100